(EXO) Exor - Overview
Sector: Industrials | Industry: Farm & Heavy Construction Machinery | Exchange: AS (Netherlands) | Market Cap: 22.350m EUR | Total Return: -22.2% in 12m
Avg Turnover: 12.4M
Qual. Beats: 0
Rev. Trend: -49.8%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Exor N.V. is a diversified holding company headquartered in the Netherlands, controlled by the Agnelli family. Its portfolio spans several capital-intensive industries, most notably the automotive sector through significant stakes in Ferrari and Stellantis. Beyond transportation, the firm maintains interests in agricultural machinery via CNH Industrial, luxury goods through Christian Louboutin, and professional sports via Juventus FC.
The company operates under a family-office investment model, focusing on long-term capital appreciation by acquiring large minority or controlling stakes in global market leaders. This structure allows Exor to navigate cyclical downturns in the automotive and construction sectors by diversifying into media, healthcare technology, and data analytics. Investors often evaluate Exor based on its Net Asset Value (NAV) relative to its market capitalization, a common metric for European investment holding companies.
Detailed performance metrics and historical valuation trends for these holdings are available on ValueRay for those conducting further analysis. Exor remains a key vehicle for exposure to European industrial engineering and global luxury branding.
- Ferrari equity performance drives net asset value and investor sentiment
- Stellantis production volume and global automotive demand impact core earnings
- Philips healthcare segment recovery influences long-term industrial investment returns
- CNH Industrial and Iveco Group performance dictates capital allocation strategy
- Discount to Net Asset Value remains primary driver of share price appreciation
| Net Income: 10.9b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.40 > 1.0 |
| NWC/Revenue: 13.09% < 20% (prev 53.27%; Δ -40.18% < -1%) |
| CFO/TA 0.08 > 3% & CFO 2.91b > Net Income 10.9b |
| Net Debt (2.15b) to EBITDA (13.2b): 0.16 < 3 |
| Current Ratio: 773.5 > 1.5 & < 3 |
| Outstanding Shares: last quarter (207.6m) vs 12m ago -7.96% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 17.90% > 50% (prev 70.81%; Δ -52.91% > 0%) |
| Interest Coverage Ratio: 54.66 > 6 (EBITDA TTM 13.2b / Interest Expense TTM 213.0m) |
| A: 0.04 (Total Current Assets 1.55b - Total Current Liabilities 2.00m) / Total Assets 37.1b |
| B: -0.02 (Retained Earnings -624.0m / Total Assets 37.1b) |
| C: 0.18 (EBIT TTM 11.6b / Avg Total Assets 66.0b) |
| D: 8.55 (Book Value of Equity 33.2b / Total Liabilities 3.89b) |
| Altman-Z'' = 10.38 = AAA |
As of May 27, 2026, the stock is trading at EUR 66.25 with a total of 298,344 shares traded.
Over the past week, the price has changed by +1.42%,
over one month by -1.35%,
over three months by -10.90% and
over the past year by -22.18%.
Exor has no consensus analysts rating.
P/S = 1.7692
P/B = 0.4113
Revenue TTM = 11.8b EUR
EBIT TTM = 11.6b EUR
EBITDA TTM = 13.2b EUR
Long Term Debt = unknown (none)
Short Term Debt = 629.0m EUR (from shortTermDebt, two quarters ago)
Debt = 3.54b EUR (from shortLongTermDebtTotal, two quarters ago) + Leases 2.00m
Net Debt = 2.15b EUR (calculated: Debt 3.54b - CCE 1.39b)
Enterprise Value = 24.5b EUR (22.4b + Debt 3.54b - CCE 1.39b)
Interest Coverage Ratio = 54.66 (Ebit TTM 11.6b / Interest Expense TTM 213.0m)
EV/FCF = 8.42x (Enterprise Value 24.5b / FCF TTM 2.91b)
FCF Yield = 11.88% (FCF TTM 2.91b / Enterprise Value 24.5b)
FCF Margin = 24.65% (FCF TTM 2.91b / Revenue TTM 11.8b)
Net Margin = 92.16% (Net Income TTM 10.9b / Revenue TTM 11.8b)
Gross Margin = unknown ((Revenue TTM 11.8b - Cost of Revenue TTM 20.0m) / Revenue TTM)
Tobins Q-Ratio = 0.66 (Enterprise Value 24.5b / Total Assets 37.1b)
Interest Expense / Debt = 6.01% (Interest Expense 213.0m / Debt 3.54b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 8.73b (EBIT 11.6b * (1 - 25.00%))
Current Ratio = 773.5 (out of range, set to none) (Total Current Assets 1.55b / Total Current Liabilities 2.00m)
Debt / Equity = 0.11 (Debt 3.54b / totalStockholderEquity, last quarter 33.2b)
Debt / EBITDA = 0.16 (Net Debt 2.15b / EBITDA 13.2b)
Debt / FCF = 0.74 (Net Debt 2.15b / FCF TTM 2.91b)
Total Stockholder Equity = 36.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.49% (Net Income 10.9b / Total Assets 37.1b)
RoE = 29.77% (Net Income TTM 10.9b / Total Stockholder Equity 36.5b)
RoCE = 31.36% (EBIT 11.6b / Capital Employed (Total Assets 37.1b - Current Liab 2.00m))
RoIC = 32.58% (EBIT 11.6b / (Assets 37.1b - Curr.Liab 2.00m - Cash 1.39b))
WACC = 7.77% (E(22.4b)/V(25.9b) * Re(8.29%) + D(3.54b)/V(25.9b) * Rd(6.01%) * (1-Tc(0.25)))
Discount Rate = 8.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -88.66 | Cagr: -5.29%
[DCF] Terminal Value 73.10% ; FCFF base≈3.81b ; Y1≈3.34b ; Y5≈2.70b
[DCF] Fair Price = 203.5 (EV 43.3b - Net Debt 2.15b = Equity 41.1b / Shares 202.2m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.27 | # QB: 0
Revenue Correlation: -49.78 | Revenue CAGR: -23.83% | SUE: 0.07 | # QB: 0
EPS current Year (2026-12-31): EPS=2.21 | Chg30d=+163.29% | Revisions=+20% | GrowthEPS=-10.5% | GrowthRev=+0.0%
EPS next Year (2027-12-31): EPS=1.26 | Chg30d=-47.82% | Revisions=-20% | GrowthEPS=-42.8% | GrowthRev=+0.0%